Sichuan Kelun-Biotech Biopharmaceutical company profile

6990 · HKEX · HKD

Compare Sichuan Kelun-Biotech Biopharmaceutical
$398.40Change from previous close: −5.59%Absolute change: −$23.60

Close · November 20, 2026

Company profile

Sichuan Kelun-Biotech Biopharmaceutical has 2,300 employees and is headquartered in Chengdu, China.

With 2,300 employees, Sichuan Kelun-Biotech develops, manufactures and sells novel medicines for oncology, immunology and metabolic conditions, serving patients in China and in overseas markets. Its pipeline rests largely on antibody-drug conjugates, among them Sac-TMT, a TROP2-directed candidate that can be used alone or alongside other treatments for advanced solid tumors, and trastuzumab botidotin for HER2-positive tumors. Further candidates include a CLDN18.2 conjugate, a Nectin-4 conjugate, the PD-L1 antibody tagitanlimab and the RET inhibitor A400. Licensing and collaboration agreements link the company to Merck Sharp & Dohme, Harbour BioMed, Windward Bio and Ellipses Pharma.

In the fiscal year ended December 2025, revenue reached 2.1 billion yuan, up 6.5% from the previous year, while the company recorded a net loss of 382.0 million yuan. The headquarters are in Chengdu. The company was incorporated in 2016 and is a subsidiary of Sichuan Kelun Pharmaceutical.

Company facts

Industry
Biotechnology
Headquarters
No. 666 Xinhua Avenue, Chengdu
Employees
2,300
Chief executive
Junyou Ge
Founded
2016
Fiscal year
January - December
Listing
6990 · HKEX
Currency
HKD
ISIN
CNE1000062J1

Sichuan Kelun-Biotech Biopharmaceutical and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
Sichuan Kelun-Biotech Biopharmaceutical6990Hong Kong SAR China$12.15B2,300-0.2%—
Sino Biopharmaceutical1177Hong Kong SAR China$11.65B22,83828.2%34.2
Pharmaron Beijing300759China$10.59B25,08814.0%39.3
Innovent Biologics1801Hong Kong SAR China$17.82B8,7547.4%105.4
ALTEOGEN196170South Korea$9.05B18147.2%97.1
Haisco Pharmaceutical Group002653China$8.97B5,59721.1%44.1

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Sichuan Kelun-Biotech Biopharmaceutical with its competitors